B Cell Immunophenotyping and Transcriptional Profiles of Memory B Cells in Patients with Myasthenia Gravis
Experimental Neurobiology
;
: 720-726, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-785786
ABSTRACT
Myasthenia gravis (MG) is an autoimmune neuromuscular junction disorders mediated by various autoantibodies. Although most patients with MG require chronic immunosuppressive treatment to control disease activity, appropriate surveillance biomarkers that monitor disease activity or potential toxicity of immunosuppressants are yet to be developed. Herein, we investigated quantitative distribution of peripheral blood B cell subsets and transcriptional profiles of memory B cells (CD19+ CD27+) in several subgroups of MG patients classified according to the Myasthenia Gravis Foundation of America (MGFA) Clinical Classification. This study suggests potential immunologic B-cell markers that may guide treatment decision in future clinical settings.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Autoanticuerpos
/
Américas
/
Linfocitos B
/
Biomarcadores
/
Inmunofenotipificación
/
Subgrupos de Linfocitos B
/
Clasificación
/
Enfermedades de la Unión Neuromuscular
/
Transcriptoma
/
Citometría de Flujo
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Experimental Neurobiology
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS